B-hGPR75 mice plus

C57BL/6JNifdc-Gpr75tm2(GPR75)Bcgen/Bcgen • 113100

B-hGPR75 mice plus

Product nameB-hGPR75 mice plus
Catalog number113100
Strain nameC57BL/6JNifdc-Gpr75tm2(GPR75)Bcgen/Bcgen
Strain backgroundC57BL/6JNifdc
NCBI gene ID10936 (Human)
AliasesGPRchr2, WI31133

このページで

  • Description
  • Targeting strategy
  • Phenotypic analysis
  • Efficacy

ポスター

すべて表示

    出版物

      Description
      • The inhibition of GPR75 may result in beneficial effects on various organ systems and in pathologies including the cerebrovascular disease, cardiovascular disease, diabetes, cancer and obesity.
      • The exons 1-2 of mouse Gpr75 gene that encode the full-length protein were replaced by human counterparts in B-hGPR75 mice plus. The promoter, 5’UTR and 3’UTR region of the mouse gene  were replaced by human counterparts. The human GPR75 expression is driven by endogenous human GPR75 promoter, while mouse Gpr75 gene transcription and translation will be disrupted.
      • Application: This product is used for pharmacodynamics and safety evaluation of GPR75 related diseases.
      Targeting strategy

      Gene targeting strategy for B-hGPR75 mice plus. The exons 1-2 of mouse Gpr75 gene that encode the full-length protein were replaced by human counterparts in B-hGPR75 mice plus. The promoter, 5’UTR and 3’UTR region of the mouse gene  were replaced by human counterparts. The human GPR75 expression is driven by endogenous human GPR75 promoter, while mouse Gpr75 gene transcription and translation will be disrupted.

      mRNA expression analysis in humanized B-hGPR75 mice plus

      Strain specific analysis of GPR75 mRNA expression in wild-type C57BL/6 mice and homozygous B-hGPR75 mice plus by RT-PCR. Brain RNA were isolated from wild-type C57BL/6 mice (+/+) and homozygous B-hGPR75 mice plus (H/H), then cDNA libraries were synthesized by reverse transcription, followed by PCR with mouse or human GPR75 primers. Mouse Gpr75 mRNA were detectable only in wild-type C57BL/6 mice. Human GPR75 mRNA was detectable only in homozygous B-hGPR75 mice plus but not in wild-type mice.

      Efficacy of GPR75 siRNA in HFD induced B-hGPR75 mice plus

      Efficacy study of GPR75 siRNA in HFD-induced B-hGPR75 mice plus. The B-hGPR75 mice plus were administered intracerebroventricular injections of BMK (GPR75 siRNA) and PBS, followed by high-fat diet induction. (A) Body weight after HFD induction. (B) Body weight change after HFD induction. (C) Food intake. (D) The weight of fat mass. Compared with PBS controls, GPR75 siRNA administration decreased body weight, weight change, food intake, and fat mass after a high-fat diet. Values are expressed as mean ± SEM.

      Note: The data comes from the client.

      * When publishing results obtained using this animal model, please acknowledge the source as follows: The animal model [B-hGPR75 mice plus] (Cat# 113100) was purchased from Biocytogen.